Loading…

Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint

The present study investigated the effects of immobilization (restraint stress) on rat chronically treated with a D 2 receptor agonist (bromocriptine, 0.4 mg/100 g body weight, injected daily intraperitoneally (ip) for 2 weeks) on plasma glucose, prolactin, and insulin levels. During restraint, the...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacology, biochemistry and behavior biochemistry and behavior, 2001-02, Vol.68 (2), p.229-233
Main Authors: Ribeiro-de-Oliveira, Antonio, Guerra, Rachel Menezes, Fóscolo, Rodrigo Bastos, Marubayashi, Umeko, Reis, Adelina Martha dos, Coimbra, Cândido Celso
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c486t-ae30ec791469d2a387f50c90e4110cfdae1599e6399468a6045d87c5973b08d73
cites cdi_FETCH-LOGICAL-c486t-ae30ec791469d2a387f50c90e4110cfdae1599e6399468a6045d87c5973b08d73
container_end_page 233
container_issue 2
container_start_page 229
container_title Pharmacology, biochemistry and behavior
container_volume 68
creator Ribeiro-de-Oliveira, Antonio
Guerra, Rachel Menezes
Fóscolo, Rodrigo Bastos
Marubayashi, Umeko
Reis, Adelina Martha dos
Coimbra, Cândido Celso
description The present study investigated the effects of immobilization (restraint stress) on rat chronically treated with a D 2 receptor agonist (bromocriptine, 0.4 mg/100 g body weight, injected daily intraperitoneally (ip) for 2 weeks) on plasma glucose, prolactin, and insulin levels. During restraint, the plasma prolactin of vehicle-treated (VEH) rats increased rapidly, reaching a peak at 10 min (57.9±8.1 ng/ml, P
doi_str_mv 10.1016/S0091-3057(00)00453-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76998526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305700004536</els_id><sourcerecordid>17859589</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-ae30ec791469d2a387f50c90e4110cfdae1599e6399468a6045d87c5973b08d73</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhq0KVJaPn9AqEhKCQ2CcxF8nRFELSEg9tBVHy9iT1lVip3YWaf99vewKjnuaOTwz7_gxIZ8oXFKg_OoHgKJ1C0ycA1wAdKyt-QeyoFK0NaNC7JHFG3JADnP-C4VquPhIDigtlTdiQZ6-pDhGm_w0-4C1D25p0VXO5xytN7OPoYp99Wc1Yfo9rCyO3lQmuGpKcTC2DFUJ8xRDxmqO635Oxof5mOz3Zsh4sq1H5Ne3rz9v7-vH73cPtzePte0kn2uDLaAVinZcuca0UvQMrALsKAXbO4OUKYW8Varj0vDyTCeFZUq0zyCdaI_I2WZvueffsqTr0WeLw2ACxmXWgislWcN3glRIpphUBWQb0KaYc8JeT8mPJq00Bb1Wr1_V67VXDaBf1et1wOdtwPJ5RPc-tXVdgNMtYLI1Q59MsD6_caprqGKFut5QWKy9eEw6W4-hfIpPaGftot9xyH-QKqBK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17859589</pqid></control><display><type>article</type><title>Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Ribeiro-de-Oliveira, Antonio ; Guerra, Rachel Menezes ; Fóscolo, Rodrigo Bastos ; Marubayashi, Umeko ; Reis, Adelina Martha dos ; Coimbra, Cândido Celso</creator><creatorcontrib>Ribeiro-de-Oliveira, Antonio ; Guerra, Rachel Menezes ; Fóscolo, Rodrigo Bastos ; Marubayashi, Umeko ; Reis, Adelina Martha dos ; Coimbra, Cândido Celso</creatorcontrib><description>The present study investigated the effects of immobilization (restraint stress) on rat chronically treated with a D 2 receptor agonist (bromocriptine, 0.4 mg/100 g body weight, injected daily intraperitoneally (ip) for 2 weeks) on plasma glucose, prolactin, and insulin levels. During restraint, the plasma prolactin of vehicle-treated (VEH) rats increased rapidly, reaching a peak at 10 min (57.9±8.1 ng/ml, P&lt;.01). In contrast, restraint failed to induce any significant change in the plasma prolactin levels of bromocriptine-treated (BR) rats. The hyperglycemic response to immobilization was 97% higher ( P&lt;.05) in BR rats than in VEH rats. Our data demonstrate that prolactin secretion and hyperglycemia in response to restraint can be dissociated by chronic treatment with BR, which also increased the hyperglycemic response to immobilization probably due to central D 2 dopaminergic activity.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/S0091-3057(00)00453-6</identifier><identifier>PMID: 11267627</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; Blood Glucose - drug effects ; Blood Glucose - metabolism ; Bromocriptine ; Bromocriptine - pharmacology ; Catecholaminergic system ; Dopamine Agonists - pharmacology ; Fundamental and applied biological sciences. Psychology ; Hyperglycemia ; Hyperglycemia - blood ; Insulin ; Insulin - blood ; Male ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Personality. Affectivity ; Pharmacology. Drug treatments ; Prolactin ; Prolactin - blood ; Prolactin - drug effects ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Rats ; Rats, Wistar ; Restraint, Physical ; Restraint-stress ; Stress ; Stress, Physiological - blood</subject><ispartof>Pharmacology, biochemistry and behavior, 2001-02, Vol.68 (2), p.229-233</ispartof><rights>2001 Elsevier Science Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-ae30ec791469d2a387f50c90e4110cfdae1599e6399468a6045d87c5973b08d73</citedby><cites>FETCH-LOGICAL-c486t-ae30ec791469d2a387f50c90e4110cfdae1599e6399468a6045d87c5973b08d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=942195$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11267627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ribeiro-de-Oliveira, Antonio</creatorcontrib><creatorcontrib>Guerra, Rachel Menezes</creatorcontrib><creatorcontrib>Fóscolo, Rodrigo Bastos</creatorcontrib><creatorcontrib>Marubayashi, Umeko</creatorcontrib><creatorcontrib>Reis, Adelina Martha dos</creatorcontrib><creatorcontrib>Coimbra, Cândido Celso</creatorcontrib><title>Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>The present study investigated the effects of immobilization (restraint stress) on rat chronically treated with a D 2 receptor agonist (bromocriptine, 0.4 mg/100 g body weight, injected daily intraperitoneally (ip) for 2 weeks) on plasma glucose, prolactin, and insulin levels. During restraint, the plasma prolactin of vehicle-treated (VEH) rats increased rapidly, reaching a peak at 10 min (57.9±8.1 ng/ml, P&lt;.01). In contrast, restraint failed to induce any significant change in the plasma prolactin levels of bromocriptine-treated (BR) rats. The hyperglycemic response to immobilization was 97% higher ( P&lt;.05) in BR rats than in VEH rats. Our data demonstrate that prolactin secretion and hyperglycemia in response to restraint can be dissociated by chronic treatment with BR, which also increased the hyperglycemic response to immobilization probably due to central D 2 dopaminergic activity.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Bromocriptine</subject><subject>Bromocriptine - pharmacology</subject><subject>Catecholaminergic system</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hyperglycemia</subject><subject>Hyperglycemia - blood</subject><subject>Insulin</subject><subject>Insulin - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Personality. Affectivity</subject><subject>Pharmacology. Drug treatments</subject><subject>Prolactin</subject><subject>Prolactin - blood</subject><subject>Prolactin - drug effects</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Restraint, Physical</subject><subject>Restraint-stress</subject><subject>Stress</subject><subject>Stress, Physiological - blood</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkU1P3DAQhq0KVJaPn9AqEhKCQ2CcxF8nRFELSEg9tBVHy9iT1lVip3YWaf99vewKjnuaOTwz7_gxIZ8oXFKg_OoHgKJ1C0ycA1wAdKyt-QeyoFK0NaNC7JHFG3JADnP-C4VquPhIDigtlTdiQZ6-pDhGm_w0-4C1D25p0VXO5xytN7OPoYp99Wc1Yfo9rCyO3lQmuGpKcTC2DFUJ8xRDxmqO635Oxof5mOz3Zsh4sq1H5Ne3rz9v7-vH73cPtzePte0kn2uDLaAVinZcuca0UvQMrALsKAXbO4OUKYW8Varj0vDyTCeFZUq0zyCdaI_I2WZvueffsqTr0WeLw2ACxmXWgislWcN3glRIpphUBWQb0KaYc8JeT8mPJq00Bb1Wr1_V67VXDaBf1et1wOdtwPJ5RPc-tXVdgNMtYLI1Q59MsD6_caprqGKFut5QWKy9eEw6W4-hfIpPaGftot9xyH-QKqBK</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Ribeiro-de-Oliveira, Antonio</creator><creator>Guerra, Rachel Menezes</creator><creator>Fóscolo, Rodrigo Bastos</creator><creator>Marubayashi, Umeko</creator><creator>Reis, Adelina Martha dos</creator><creator>Coimbra, Cândido Celso</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint</title><author>Ribeiro-de-Oliveira, Antonio ; Guerra, Rachel Menezes ; Fóscolo, Rodrigo Bastos ; Marubayashi, Umeko ; Reis, Adelina Martha dos ; Coimbra, Cândido Celso</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-ae30ec791469d2a387f50c90e4110cfdae1599e6399468a6045d87c5973b08d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Bromocriptine</topic><topic>Bromocriptine - pharmacology</topic><topic>Catecholaminergic system</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hyperglycemia</topic><topic>Hyperglycemia - blood</topic><topic>Insulin</topic><topic>Insulin - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Personality. Affectivity</topic><topic>Pharmacology. Drug treatments</topic><topic>Prolactin</topic><topic>Prolactin - blood</topic><topic>Prolactin - drug effects</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Restraint, Physical</topic><topic>Restraint-stress</topic><topic>Stress</topic><topic>Stress, Physiological - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ribeiro-de-Oliveira, Antonio</creatorcontrib><creatorcontrib>Guerra, Rachel Menezes</creatorcontrib><creatorcontrib>Fóscolo, Rodrigo Bastos</creatorcontrib><creatorcontrib>Marubayashi, Umeko</creatorcontrib><creatorcontrib>Reis, Adelina Martha dos</creatorcontrib><creatorcontrib>Coimbra, Cândido Celso</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ribeiro-de-Oliveira, Antonio</au><au>Guerra, Rachel Menezes</au><au>Fóscolo, Rodrigo Bastos</au><au>Marubayashi, Umeko</au><au>Reis, Adelina Martha dos</au><au>Coimbra, Cândido Celso</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>68</volume><issue>2</issue><spage>229</spage><epage>233</epage><pages>229-233</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>The present study investigated the effects of immobilization (restraint stress) on rat chronically treated with a D 2 receptor agonist (bromocriptine, 0.4 mg/100 g body weight, injected daily intraperitoneally (ip) for 2 weeks) on plasma glucose, prolactin, and insulin levels. During restraint, the plasma prolactin of vehicle-treated (VEH) rats increased rapidly, reaching a peak at 10 min (57.9±8.1 ng/ml, P&lt;.01). In contrast, restraint failed to induce any significant change in the plasma prolactin levels of bromocriptine-treated (BR) rats. The hyperglycemic response to immobilization was 97% higher ( P&lt;.05) in BR rats than in VEH rats. Our data demonstrate that prolactin secretion and hyperglycemia in response to restraint can be dissociated by chronic treatment with BR, which also increased the hyperglycemic response to immobilization probably due to central D 2 dopaminergic activity.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11267627</pmid><doi>10.1016/S0091-3057(00)00453-6</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-3057
ispartof Pharmacology, biochemistry and behavior, 2001-02, Vol.68 (2), p.229-233
issn 0091-3057
1873-5177
language eng
recordid cdi_proquest_miscellaneous_76998526
source ScienceDirect Freedom Collection 2022-2024
subjects Animals
Biological and medical sciences
Blood Glucose - drug effects
Blood Glucose - metabolism
Bromocriptine
Bromocriptine - pharmacology
Catecholaminergic system
Dopamine Agonists - pharmacology
Fundamental and applied biological sciences. Psychology
Hyperglycemia
Hyperglycemia - blood
Insulin
Insulin - blood
Male
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Personality. Affectivity
Pharmacology. Drug treatments
Prolactin
Prolactin - blood
Prolactin - drug effects
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Rats
Rats, Wistar
Restraint, Physical
Restraint-stress
Stress
Stress, Physiological - blood
title Bromocriptine-induced dissociation of hyperglycemia and prolactin response to restraint
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A31%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bromocriptine-induced%20dissociation%20of%20hyperglycemia%20and%20prolactin%20response%20to%20restraint&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Ribeiro-de-Oliveira,%20Antonio&rft.date=2001-02-01&rft.volume=68&rft.issue=2&rft.spage=229&rft.epage=233&rft.pages=229-233&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/S0091-3057(00)00453-6&rft_dat=%3Cproquest_cross%3E17859589%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c486t-ae30ec791469d2a387f50c90e4110cfdae1599e6399468a6045d87c5973b08d73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17859589&rft_id=info:pmid/11267627&rfr_iscdi=true